Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:34 PM ET 10-Q
Financial Results Recursion Pharmaceuticals, Inc. RXRX

Recursion Pharmaceuticals Q3 2026 Results: Net Loss of $119M, Loss Narrows

Recursion Pharmaceuticals reported a net loss of $119.0 million for the third quarter of 2026, an improvement from the $162.3 million loss in the prior year period. Total revenue increased significantly to $18.6 million for the quarter, while the company maintained a strong liquidity position with $549.9 million in cash and cash equivalents as of September 30, 2026.

Key figure
Net loss $119M
4:34 PM ET 8-K
Financial Results Chemours Co CC

Chemours Financial Results

Chemours reported third quarter 2026 net sales of $1.5 billion, driven by a 10% pricing increase in Titanium Technologies and 26% growth in APM Performance Solutions. The company achieved net income of $196 million, significantly up from $46 million in the prior-year quarter, while also completing the sale of its Kuan Yin property for approximately $340 million.

“Our third-quarter results demonstrate strong year-over-year performance in TT and APM, reflecting pricing execution in TiO2 and increased demand across Performance Solutions’ high-value AI infrastructure including data center and semiconductor end markets.”

Denise Dignam, Chemours President and CEO

“We also continued to make meaningful progress under our Pathway to Thrive, including reaching a settlement with the State of North Carolina, driving operational improvements through the Chemours Business System, and closing the sale of the final parcel of land associated with our former Kuan Yin property.”

Denise Dignam, Chemours President and CEO
4:33 PM ET 8-K
Financial Results Recursion Pharmaceuticals, Inc. RXRX

Recursion Pharmaceuticals Financial Results

Recursion Pharmaceuticals reported Q3 2026 financial results, highlighting clinical data for REC-4881 and REC-1245 and the appointment of Fred Hassan as Chair of the Board. The company extended its cash runway into 2029 following an October follow-on offering and noted that Sanofi has optioned the first development candidate from their collaboration.

Term
Q3 2026

“To pioneer a new blueprint for making medicines with AI, we believe you have to tie together three core capabilities in one engine: uncover novel biology, design differentiated molecules against challenging targets, and generate clinical evidence that matters for patients.”

Najat Khan, Ph.D., President and Chief Executive Officer of Recursion
4:33 PM ET 10-Q
Financial Results Capital Southwest Corp CSWC ▶ Call

Capital Southwest Q2 2026 Results: Net Income $21.4M, Down 16.3% YoY

Capital Southwest reported a net increase in net assets from operations of $46.2 million for the six months ended September 30, 2026, compared to $52.6 million in the prior year period. Total investment income grew to $128.2 million from $112.9 million, while the company expanded its investment portfolio to $2.4 billion at fair value.

Key figure
Net income $21.4M · -16.3% YoY
4:32 PM ET 10-Q
Financial Results Inspire Medical Systems, Inc. INSP ▶ Call

Inspire Medical Systems Q3 2026 Results: Net Loss of $24.4M

For the nine months ended September 30, 2026, Inspire Medical Systems reported a net loss of $35.4 million on revenue of $611.9 million, compared to a net profit of $9.3 million in the prior year period. The shift to a loss was driven by a decrease in revenue and a significant increase in selling, general, and administrative expenses.

Key figure
Net loss $24.4M
4:32 PM ET 10-Q
Financial Results Upwork, Inc UPWK

Upwork Q3 2026 Results: Net Income $31.8M, Up 8.4% YoY

Upwork reported a decrease in revenue to $185.6 million for the third quarter of 2026 compared to $201.7 million in the prior year. Despite lower revenue, net income increased to $31.8 million for the quarter, driven by a significant reduction in operating expenses, particularly in research and development and sales and marketing.

Key figure
Net income $31.8M · +8.4% YoY
4:31 PM ET 10-Q
Financial Results Axsome Therapeutics, Inc. AXSM

Axsome Therapeutics Q3 2026 Results: Net Loss of $12.9M, Loss Narrows

Axsome Therapeutics reported total revenues of $259.7 million for the third quarter of 2026, driven primarily by product sales of AUVELITY, SUNOSI, and SYMBRAVO. While the company remains in a net loss position of $12.9 million for the quarter, this represents a significant improvement from the $47.2 million loss in the prior year period as commercial scale increases.

Key figure
Net loss $12.9M
4:31 PM ET 8-K
Financial Results Fabrinet FN

Fabrinet Financial Results

Fabrinet reported record first quarter fiscal 2027 revenue of $1.47 billion, a 51% increase year-over-year, driven by broad-based demand and new product ramps. The company also expanded its share repurchase program by $103 million and issued strong guidance for the second quarter.

Term
Q1 2027

“Fiscal year 2027 is off to an excellent start with record revenue and non-GAAP earnings per share that were well above our guidance ranges. Broad-based demand across multiple significant programs drove these results, with new product ramps further supporting our growth. We enter the second quarter with exceptional momentum that makes us confident that we can deliver another strong performance.”

Seamus Grady, Chairman and Chief Executive Officer of Fabrinet
4:31 PM ET 10-Q
Financial Results Boise Cascade Co BCC

Boise Cascade Q3 2026 Results: Net Income $36.4M, Up 67.2% YoY

For the quarter ended September 30, 2026, Boise Cascade reported sales of $1.8 billion and net income of $36.4 million, an increase from $21.8 million in the prior year period. While nine-month net income decreased slightly year-over-year to $111.6 million, the company maintained a strong liquidity position with $385.1 million in cash and cash equivalents.

Key figure
Net income $36.4M · +67.2% YoY
4:31 PM ET 10-Q
Financial Results Odyssey Marine Exploration Inc OMEX

Odyssey Marine Exploration Q3 2026 Results: Net Loss of $4.64M, Loss Narrows

Odyssey Marine Exploration reported a net loss of $13.6 million for the nine months ended September 30, 2026, an improvement from the $25.7 million loss in the prior year period. The company's balance sheet shows a significant stockholders' deficit of $84.4 million and a substantial increase in current loans payable to $14.9 million.

Key figure
Net loss $4.64M
4:31 PM ET 8-K
Financial Results Apple Inc. AAPL

Apple Financial Results

Apple reported record fourth quarter revenue of $114.5 billion, driven by all-time highs in Services revenue and a September quarter record for iPhone sales. The company achieved diluted EPS of $2.10 and returned $28 billion to shareholders during the quarter while declaring a cash dividend of $0.27 per share.

Term
Q4 2026

“Today, Apple is proud to report a September quarter revenue record of $114.5 billion, up 12 percent from a year ago, with iPhone reaching a September quarter record and Services reaching an all-time high, capping off our best fiscal year ever.”

John Ternus, Apple’s CEO

“Apple delivered September quarter records for net income and EPS. Our record September quarter capped off a strong fiscal 2026, with all-time record revenue of $479 billion and double-digit EPS growth.”

Kevan Parekh, Apple’s CFO
4:31 PM ET 8-K
Financial Results Huntsman Corp HUN

Huntsman Financial Results

Huntsman Corporation reported Q3 2026 revenue of $1.72 billion, a significant increase from $1.46 billion in the prior year period. The company narrowed its net loss to $18 million and achieved positive adjusted net income of $7 million, driven by higher volumes and cost savings. Additionally, the company noted that shareholders approved its pending merger of equals with Olin Corporation during the quarter.

Term
Q3 2026

“Our Company continues to perform solidly despite significant macroeconomic and industry challenges. Year-over-year improvement was driven by higher volumes, stronger margins, and cost savings. Better results and cash flow are expected to reduce net debt leverage to approximately 4 times by year-end, a significant improvement from the beginning of the year. These gains reflect our associates’ hard work and disciplined execution to grow volumes, lower costs, and generate cash.”

Peter R. Huntsman, Chairman, President, and CEO
4:30 PM ET 10-Q
Financial Results Greenlight Capital Re, Ltd. GLRE ▶ Call

Greenlight Capital Re Q3 2026 Results: Turns Profitable, Net Income $3.23M

Greenlight Capital Re reported net income of $9.4 million for the first nine months of 2026, a decrease from $25.6 million in the prior year period, primarily driven by higher gross premiums ceded and investment losses. Total shareholders' equity decreased to $694.5 million as of September 30, 2026, reflecting $27.2 million in share repurchases during the period.

Key figure
Net income $3.23M
4:30 PM ET 8-K
Financial Results ONE Gas, Inc. OGS

ONE Gas Financial Results

ONE Gas reported third quarter 2026 adjusted net income of $33.5 million, or $0.53 per diluted share, and raised its full-year 2026 adjusted EPS guidance. The company also declared a quarterly dividend of $0.68 per share and noted that its 2026 financing plan is now complete following a $375 million senior notes issuance in August.

Term
Q3 2026

“In the third quarter, we again delivered positive results and, for the second time this year, raise our 2026 financial outlook. Our 2026 financing plan is complete, and we see continued opportunity ahead as diverse large-load demand develops across our footprint. Importantly, we expect our average 2026 customer bills to remain flat to last year.”

Robert S. McAnnally, chief executive officer
4:30 PM ET 8-K
Financial Results Inspire Medical Systems, Inc. INSP

Inspire Medical Systems Financial Results

Inspire Medical Systems reported Q3 2026 revenue of $206.7 million, a 7.9% decrease year-over-year primarily due to U.S. coding and reimbursement challenges. Despite the revenue decline, the company achieved a positive adjusted diluted EPS of $0.14 and noted that the AMA approved new Category I CPT codes for its Inspire V system effective 2028.

Term
3 months

“We are pleased to have delivered sequential growth in the third quarter, with U.S. performance coming in ahead of our expectations. Results suggest that, despite some lingering headwinds, there is greater comfort among implanting physicians with the current coding dynamic.”

Tim Herbert, Chairman and CEO of Inspire Medical Systems

“Looking further ahead, we were also pleased with the AMA Editorial Panel’s September approval of a new CPT® code for single lead HGNS devices, including the Inspire V system. When this takes effect in January 2028, a dedicated code set will give physicians and hospitals enhanced clarity around coding and reimbursement and, in turn, further enable patient access to Inspire therapy.”

Tim Herbert, Chairman and CEO of Inspire Medical Systems
4:29 PM ET 8-K
Financial Results Metallus Inc. MTUS

Metallus Financial Results

Metallus Inc. reported third-quarter 2026 net sales of $337.2 million and net income of $23.8 million, driven by strong demand in the aerospace and defense sectors. The company achieved its $250 million annualized run-rate sales target for aerospace & defense and secured a major U.S. Defense Logistics Agency contract valued at up to $995 million over five years.

Term
Q3 2026

“Our third-quarter performance reflects continued execution of our strategic priorities, as we delivered higher adjusted EBITDA both sequentially and year over year. We are pleased to have achieved our annualized $250 million run-rate sales target for aerospace & defense this quarter. The continued expansion of favorable product mix and disciplined pricing actions coupled with strength across all end markets allowed us to deliver the third straight quarter of year-over-year improved profitability.”

Mike Williams, chief executive officer
4:29 PM ET 10-Q
Financial Results Idexx Laboratories Inc IDXX

Idexx Laboratories Q3 2026 Results: Net Income $317M, Up 15.5% YoY

IDEXX Laboratories reported total revenue of $1.21 billion for the quarter ended September 30, 2026, representing growth over the $1.11 billion reported in the prior year. Net income for the nine months ended September 30, 2026, increased to $934 million, up from $811 million in the same period of 2025, driven by strong performance in both product and service revenue.

Key figure
Net income $317M · +15.5% YoY
4:28 PM ET 8-K
Financial Results Lattice Semiconductor Corp LSCC

Lattice Semiconductor Financial Results

Lattice Semiconductor reported record Q3 2026 revenue of $291.0 million, a 118% year-over-year increase driven by strong FPGA demand in data center AI and industrial applications. The results include the first partial quarter of contribution from the AMI acquisition completed in July 2026. The company provided strong Q4 guidance, expecting revenue to grow approximately 130% year-over-year.

Term
Q3 2026

“We delivered record third quarter revenue of $291 million and non-GAAP EPS of $0.72, up 118% and approximately 160% year-over-year, respectively. FPGA revenue grew approximately 90%, fueled by accelerating data center AI demand and continued momentum across Industrial & Embedded applications. Strong bookings, backlog and design wins support our fourth-quarter revenue outlook of approximately $335 million and reinforce our confidence in growth into 2027 and beyond.”

Ford Tamer, Chief Executive Officer

“Lattice’s operating leverage was evident in the third quarter as we translated accelerating demand into faster year-over-year earnings growth. We continue to execute against our growth strategy by investing to strengthen our leadership in small and mid-range FPGAs, expanding our combined Lattice and AMI solutions portfolio, and advancing our companion chip opportunity.”

Lorenzo Flores, Chief Financial Officer
4:23 PM ET 8-K
Financial Results Herbalife Ltd. HLF

Herbalife Financial Results

Herbalife reported third quarter 2026 net sales of $1.35 billion, representing 6.0% year-over-year growth and its fifth consecutive quarter of expansion. The company also announced a new $250 million share repurchase program and the appointment of Scott Schaefer as CFO.

Term
Q3 2026
4:22 PM ET 8-K
Financial Results Great Elm Capital Corp. GECC

Great Elm Capital Financial Results

Great Elm Capital Corp. reported Q3 2026 financial results with Net Investment Income of $0.17 per share and a Net Asset Value of $7.40 per share. The company declared a $0.25 per share distribution for Q4 2026 and highlighted the repurchase of approximately 350,000 shares year-to-date at a significant discount to NAV.

Term
Q3 2026

“Our third quarter results reflect a challenging credit environment and continued pressure on certain portfolio investments, particularly our CLO joint venture. While net investment income and NAV declined during the quarter, we remain focused on strengthening portfolio performance, maintaining disciplined underwriting standards and positioning GECC for more consistent earnings and long-term value creation.”

Jason Reese, Chairman of the Board of Directors and Chief Executive Officer

“Looking ahead, we believe our growing pipeline of differentiated investments, strong liquidity position and continued focus on portfolio optimization provide a solid foundation for improving earnings performance and creating long-term shareholder value.”

Jason Reese, Chairman of the Board of Directors and Chief Executive Officer
4:22 PM ET 8-K
Financial Results Aehr Test Systems AEHR

Aehr Test Systems Financial Results

Aehr Test Systems reported record Q1 fiscal 2027 revenue of $33.0 million, a 200% increase year-over-year, driven by strong demand for AI semiconductor test and burn-in solutions. The company raised its full-year revenue guidance to $150 million and reported a substantial effective backlog of $109.3 million.

Term
Q1 2027

“Our fiscal first quarter results demonstrate the accelerating demand for our AI semiconductor test and burn-in solutions and our ability to execute against expanding customer production requirements.”

Gayn Erickson, President and CEO

“Based on our first quarter performance, substantial backlog, and visibility into customer production requirements, we are raising our fiscal 2027 revenue outlook to $150 million, compared with our previous guidance range of $130 million to $150 million.”

Gayn Erickson, President and CEO
4:21 PM ET 10-Q
Financial Results Great Elm Capital Corp. GECC

Great Elm Capital Q3 2026 Results: Net Loss of $4.23M, Loss Narrows

Great Elm Capital Corp. is a business development company (BDC) focused on senior secured debt and specialty finance investments. As of October 26, 2026, the company had 13,659,450 shares outstanding and continues to operate through its specialty finance subsidiary, GESF, and its CLO Formation JV.

Key figure
Net loss $4.23M
4:21 PM ET 10-Q
Financial Results Crawford & Co CRD-A

Crawford & Q3 2026 Results: Net Income $15M, Up 21.0% YoY

Crawford & Company reported net income of $15.0 million for the quarter ended September 30, 2026, an increase from $12.4 million in the prior year period. While total revenues slightly decreased to $329.9 million, the company improved profitability through lower costs of services and reduced interest expenses.

Key figure
Net income $15M · +21.0% YoY
4:21 PM ET 10-Q
Financial Results Bioventus Inc. BVS

Bioventus Q3 2026 Results: Net Income $5.99M, Up 89.8% YoY

Bioventus Inc. filed its Q3 2026 10-Q reporting on the period ended September 26, 2026, noting 68,474,219 shares of Class A common stock outstanding. The company is currently undergoing a strategic alternatives review process while managing risks related to debt covenants under its 2025 Credit Agreement and potential FDA reclassification of its HA products.

Key figure
Net income $5.99M · +89.8% YoY
4:20 PM ET 8-K
Financial Results Boise Cascade Co BCC

Boise Cascade Financial Results

Boise Cascade reported third quarter 2026 net income of $36.4 million on sales of $1.8 billion, representing a 67% increase in net income compared to the prior year period. The results were driven by strong performance in the Wood Products segment and a 7% increase in Building Materials Distribution sales despite a softer housing market.

Term
Q3 2026

“In the third quarter of 2026, we delivered strong financial results despite softer housing starts, demonstrating the resilience of our integrated distribution and wood products platform.”

Jeff Strom, CEO

“As we close out 2026 and look ahead to 2027, we remain focused on integrating new specialty product lines, driving efficiencies, and supporting our customers and suppliers with the in-stock availability and next-day delivery capabilities they value in a more cautious demand environment.”

Jeff Strom, CEO
4:20 PM ET 8-K
Financial Results Celanese Corp CE

Celanese Financial Results

Celanese Corporation reported Q3 2026 adjusted earnings of $1.65 per share, a 23% increase year-over-year, and generated $461 million in free cash flow. The company highlighted strategic progress including the closure of its Lanaken acetate tow facility and the pending sale of an additional 19% interest in the Nutrinova joint venture for $152 million.

Term
Q3 2026

“Today, we reported third quarter 2026 adjusted earnings per share of $1.65 (inclusive of approximately $0.36 per share of non-cash transaction amortization), representing a 23 percent increase compared to the same period last year. I am also pleased to report that we generated $461 million of free cash flow in the quarter.”

Scott Richardson, Celanese Corporation, President and Chief Executive Officer

“Over the last two years, we have taken significant actions to improve the company's competitiveness, earnings quality, and cash generation. As a result, we expect to generate more than $1.5 billion in free cash flow across 2025 and 2026, demonstrating our ability to drive strong financial performance while making meaningful progress on deleveraging.”

Scott Richardson, Celanese Corporation, President and Chief Executive Officer
4:20 PM ET 10-Q
Financial Results Cerus Corp CERS ▶ Call

Cerus Q3 2026 Results: Net Loss of $550K, Loss Widens

For the quarter ended September 30, 2026, Cerus Corporation reported product revenue of $57.7 million, a 9.5% increase over the prior year, and achieved a narrow net loss of $0.6 million. The company significantly reduced its nine-month net loss from $13.5 million in 2025 to $5.2 million in 2026, driven by higher gross profits and lower research and development expenses.

Key figure
Net loss $550K
4:20 PM ET 8-K
Financial Results UDR, Inc. UDR

UDR Financial Results

UDR, Inc. reported third quarter 2026 financial results, including net income of $0.67 per diluted share and FFOA of $0.65 per diluted share. The company raised its full-year 2026 FFOA guidance midpoint to $2.55 and increased its same-store NOI growth outlook to 1.0%. Management noted that operational results exceeded expectations, leading to the second guidance raise of the year.

Term
Q3 2026

“Third quarter operational results and FFOA per diluted share exceeded our expectations and drove our second guidance raise of 2026.”

Eli Toomey, President and CEO
4:19 PM ET 10-Q
Financial Results On Semiconductor Corp ON

On Semiconductor Q3 2026 Results: Net Income $314M, Up 23.1% YoY

ON Semiconductor reported revenue of $1,722.3 million for the quarter ended October 2, 2026, an increase from $1,550.9 million in the prior year. Net income attributable to the company rose to $313.9 million compared to $255.0 million, while the nine-month period showed a significant recovery with an operating income of $583.5 million versus a loss in the previous year.

Key figure
Net income $314M · +23.1% YoY
4:19 PM ET 8-K
Financial Results Crawford & Co CRD-A

Crawford & Financial Results

Crawford & Company reported third quarter 2026 financial results with net income of $15.0 million, up 21% from the prior year period. While revenues before reimbursements decreased slightly to $321.6 million, the company saw improved operating performance led by its International segment and weather-related claims activity.

Term
Q3 2026

“Our third-quarter performance demonstrated Crawford’s ability to deliver improved operating results even in a mixed claims environment. Our earnings exceeded the prior year and were supported by weather-related claims activity and disciplined cost management in our International segment.”

Bruce Swain, president and chief executive officer of Crawford & Company

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.